Galectin-3 Gene Inactivation Reduces Atherosclerotic Lesions and Adventitial Inflammation in ApoE-Deficient Mice
- 1 January 2008
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 172 (1) , 247-255
- https://doi.org/10.2353/ajpath.2008.070348
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Perivascular Mast Cells Promote Atherogenesis and Induce Plaque Destabilization in Apolipoprotein E–Deficient MiceCirculation, 2007
- Toxoplasma gondii Infection Reveals a Novel Regulatory Role for Galectin-3 in the Interface of Innate and Adaptive ImmunityThe American Journal of Pathology, 2006
- Innate and acquired immunity in atherogenesisNature Medicine, 2002
- Atherosclerotic Lesions Grow Through Recruitment and Proliferation of Circulating Monocytes in a Murine ModelThe American Journal of Pathology, 2002
- The Role of Galectin-3 in Endocytosis of Advanced Glycation End Products and Modified Low Density LipoproteinsBiochemical and Biophysical Research Communications, 2001
- Adventitial infiltrates associated with advanced atherosclerotic plaques: structural organization suggests generation of local humoral immune responsesThe Journal of Pathology, 2000
- Role of galectin-3 as a receptor for advanced glycosylation end productsKidney International, 2000
- Embryonic implantation in galectin 1/galectin 3 double mutant miceDevelopmental Dynamics, 1998
- Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein EScience, 1992
- Angiogenic activity of adipose tissueBiochemical and Biophysical Research Communications, 1988